Quality
Faisal Alsaqri, MSc, CLBSSB
Laboratry Operations and quality Improvment analyst
King Abdulaziz Medical City -Riyadh, Ar Riyad, Saudi Arabia
Disclosure(s): No financial relationships to disclose
Faisal Alsaqri, MSc, CLBSSB
Laboratry Operations and quality Improvment analyst
King Abdulaziz Medical City -Riyadh, Ar Riyad, Saudi Arabia
Disclosure(s): No financial relationships to disclose
Hillary Brown, BS, MLT (she/her/hers)
Compliance Specialist CTTL
Massachusetts General Hospital Cellular Therapy Lab (CTTL), Massachusetts, United States
Disclosure(s): No financial relationships to disclose
This session equips blood bank, transfusion medicine, and biotherapies professionals with practical tools for robust risk assessment. Risk identification methods and customizing risk registers for specific practice areas will be covered. Key steps in the risk assessment process like evaluation, prioritization and monitoring will be explored. Techniques for proactively assessing vulnerabilities across the full spectrum of operations, from donor screening and component preparation to blood administration will be discussed. Best practices for risk assessment, including evaluating risk levels and predictability, will be presented. Real case examples demonstrate how targeted risk mitigation enhances patient outcomes and ensures the safety of blood and biotherapies. Attendees will gain skills applicable to establishing customized risk management programs tailored to their unique needs.
CABP CE Eligible